adamantane has been researched along with alpha-aminopyridine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basak, G; Czajkowski, K; Dziembowska, M; Górska, A; Gołab, J; Grzela, T; Jalili, A; Kamińska, B; Kasprzycka, M; Kazimierczuk, Z; Lasek, W; Maj, M; Mikłaszewicz, P; Młynarczuk, I; Nowaczyk, M; Nowis, D; Sieńko, J; Switaj, T | 1 |
| Chopra, S; Dasgupta, A; De Groote, MA; Soni, I | 1 |
| Czajkowski, K; Lasek, W; Sieńko, J; Smolarczyk, R; Teliga-Czajkowska, J | 1 |
| Akakpo, S; Chalon, S; Chughlay, MF; Csermak-Renner, K; Djeriou, E; Gaur, AH; Leboulleux, D; McCarthy, J; Odedra, A; Shanks, GD; Winnips, C | 1 |
| Deng, Y; Huang, M; Jia, S; Li, L; Li, Y; Luo, T; Peng, H; Wang, E; Wang, L; Wu, S; Xiong, P; Yang, Q; Yang, Y; Yao, B; Zhang, S | 1 |
1 review(s) available for adamantane and alpha-aminopyridine
| Article | Year |
|---|---|
Challenges facing the drug discovery pipeline for non-tuberculous mycobacteria.
Topics: Adamantane; Aminopyridines; Anti-Bacterial Agents; Azepines; Benzamides; Clinical Trials as Topic; Diarylquinolines; Drug Discovery; Ethylenediamines; Fluoroquinolones; Humans; Minocycline; Mycobacterium Infections, Nontuberculous; Nitroimidazoles; Nontuberculous Mycobacteria; Oxazoles; Piperazines; Spiro Compounds; Thiazines; Tigecycline; Uridine | 2016 |
4 other study(ies) available for adamantane and alpha-aminopyridine
| Article | Year |
|---|---|
Stimulation of TNF-alpha production by 2-(1-adamantylamino)-6-methylpyridine (AdAMP) - a novel immunomodulator with potential application in tumour immunotherapy.
Topics: Adamantane; Aminopyridines; Animals; Female; Humans; Melanoma; Mice; NF-kappa B; Ovarian Neoplasms; RNA, Messenger; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2002 |
Potentialization of N-a-tosyl-L-phenylalanine chloromethyl ketone (TPCK) cytotoxic activity by 2-(1-adamantylamino)-6-methylpyridine (AdAMP) in human ovarian cancer cells.
Topics: Adamantane; Aminopyridines; Apoptosis; Cell Line, Tumor; Cell Survival; Drug Synergism; Female; Humans; Infliximab; Ovarian Neoplasms; Signal Transduction; Tosylphenylalanyl Chloromethyl Ketone; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2017 |
Liver Enzyme Elevations in
Topics: Acrylamides; Adamantane; Adult; Alanine Transaminase; Aminopyridines; Aminoquinolines; Antimalarials; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Erythrocyte Transfusion; Erythrocytes; Female; Ferrous Compounds; Healthy Volunteers; Heterocyclic Compounds, 4 or More Rings; Humans; Indoles; Isoquinolines; Malaria, Falciparum; Male; Metallocenes; Parasitemia; Peroxides; Piperazines; Plasmodium falciparum; Primaquine; Pyrimidines; Quinolines; Spiro Compounds; Sulfones; Triazoles; Young Adult | 2020 |
Screening for Active Compounds Targeting Human Natural Killer Cell Activation Identifying Daphnetin as an Enhancer for IFN-γ Production and Direct Cytotoxicity.
Topics: Acetanilides; Adamantane; Adolescent; Adult; Aminopyridines; Cytotoxicity, Immunologic; Drug Evaluation, Preclinical; Enzyme Inhibitors; Female; Humans; Hydrazones; Hydroxyquinolines; Interferon-gamma; Interleukin-12; K562 Cells; Killer Cells, Natural; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Middle Aged; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pyridazines; Pyrimidines; Signal Transduction; TOR Serine-Threonine Kinases; Umbelliferones; Young Adult | 2021 |